25C-NBMD

A synthetic psychedelic compound

25C-NBMD is a synthetic psychedelic compound that belongs to the phenethylamine class. It is a derivative of the 2C family of phenethylamines, specifically related to 2C-C, and is part of the NBOMe series, which are known for their potent effects at low doses.

Chemical Structure and Properties

25C-NBMD is chemically similar to 25C-NBOMe, with the primary difference being the substitution of a methoxybenzyl group in place of the methoxy group. This modification results in a compound that retains the potent psychedelic effects characteristic of the NBOMe series.

The IUPAC name for 25C-NBMD is 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. Its molecular formula is C18H22ClNO3, and it has a molecular weight of 335.83 g/mol.

Pharmacology

25C-NBMD acts primarily as a partial agonist at the 5-HT2A receptor, which is the primary target for classical psychedelics such as LSD and psilocybin. The activation of this receptor is responsible for the psychedelic effects experienced by users.

The compound is known for its high potency, meaning that only a small amount is needed to produce significant effects. This is a characteristic feature of the NBOMe series, which are often active at microgram doses.

Effects

The effects of 25C-NBMD are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in thought processes. Users may experience enhanced colors, patterns, and a sense of euphoria.

The onset of effects typically occurs within 30 to 90 minutes after administration, with the peak effects lasting for several hours. The total duration of effects can range from 6 to 10 hours, depending on the dose and individual metabolism.

Safety and Toxicity

As with other NBOMe compounds, 25C-NBMD can be dangerous if misused. The high potency of the compound increases the risk of overdose, which can lead to severe adverse effects such as vasoconstriction, hypertension, and tachycardia. There have been reports of fatalities associated with the use of NBOMe compounds, often due to misidentification or improper dosing.

Legal Status

The legal status of 25C-NBMD varies by country. In some jurisdictions, it may be classified as a controlled substance, while in others it may remain unregulated. Users should be aware of the legal implications of possessing or distributing this compound in their region.

Also see

• 2C-C
• 25C-NBOMe
• Psychedelic drug
• 5-HT2A receptor